SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-002891
Filing Date
2019-02-14
Accepted
2019-02-13 19:01:35
Documents
57
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q urov-10q_20181231.htm 10-Q 2055208
2 EX-10.1 urov-ex101_104.htm EX-10.1 74549
3 EX-31.1 urov-ex311_9.htm EX-31.1 17843
4 EX-31.2 urov-ex312_7.htm EX-31.2 17958
5 EX-32.1 urov-ex321_8.htm EX-32.1 9684
6 EX-32.2 urov-ex322_6.htm EX-32.2 9727
7 GRAPHIC gowulbhwdyck000001.jpg GRAPHIC 25770
  Complete submission text file 0001564590-19-002891.txt   5155702

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT urov-20181231.xml EX-101.INS 767834
9 XBRL TAXONOMY EXTENSION SCHEMA urov-20181231.xsd EX-101.SCH 37291
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urov-20181231_cal.xml EX-101.CAL 31497
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urov-20181231_def.xml EX-101.DEF 125568
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE urov-20181231_lab.xml EX-101.LAB 280071
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urov-20181231_pre.xml EX-101.PRE 227578
Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38667 | Film No.: 19599798
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1